- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 14, 2025 | 25.75M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $7.51M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $14.1M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $5.2M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $13.31M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $17.64M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $22.35M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $19.35M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $18.73M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $10.12M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $20.72M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $12.1M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 16.56M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$2.68M |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | −$2.47M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | −$2.15M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.19 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.19 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $5.09M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $4.3M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$3.21M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$2.14M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $2.95M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $3.38M |
| Revenue | Q1 2025 · Mar 31, 2024 | $6.33M |